JP2009500298A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009500298A5 JP2009500298A5 JP2008517193A JP2008517193A JP2009500298A5 JP 2009500298 A5 JP2009500298 A5 JP 2009500298A5 JP 2008517193 A JP2008517193 A JP 2008517193A JP 2008517193 A JP2008517193 A JP 2008517193A JP 2009500298 A5 JP2009500298 A5 JP 2009500298A5
- Authority
- JP
- Japan
- Prior art keywords
- epitope
- sequence
- composition
- linker
- isolated polypeptide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US69057405P | 2005-06-15 | 2005-06-15 | |
| US60/690,574 | 2005-06-15 | ||
| PCT/US2006/023672 WO2006138675A2 (en) | 2005-06-15 | 2006-06-15 | Her-2 peptides |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012093680A Division JP5542865B2 (ja) | 2005-06-15 | 2012-04-17 | Ｈｅｒ−２ペプチド |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2009500298A JP2009500298A (ja) | 2009-01-08 |
| JP2009500298A5 true JP2009500298A5 (https=) | 2009-07-30 |
| JP5222134B2 JP5222134B2 (ja) | 2013-06-26 |
Family
ID=37571268
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008517193A Expired - Fee Related JP5222134B2 (ja) | 2005-06-15 | 2006-06-15 | Ｈｅｒ−２ペプチド |
| JP2012093680A Expired - Fee Related JP5542865B2 (ja) | 2005-06-15 | 2012-04-17 | Ｈｅｒ−２ペプチド |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012093680A Expired - Fee Related JP5542865B2 (ja) | 2005-06-15 | 2012-04-17 | Ｈｅｒ−２ペプチド |
Country Status (7)
| Country | Link |
|---|---|
| US (3) | US7691396B2 (https=) |
| EP (1) | EP1912680B1 (https=) |
| JP (2) | JP5222134B2 (https=) |
| AU (1) | AU2006261342B2 (https=) |
| CA (1) | CA2612394C (https=) |
| ES (1) | ES2531483T3 (https=) |
| WO (1) | WO2006138675A2 (https=) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1246597B1 (en) * | 1999-08-03 | 2015-01-14 | The Ohio State University | Polypeptides and polynucleotides for enhancing immune reactivity to her-2 protein |
| AU2006261342B2 (en) | 2005-06-15 | 2012-02-02 | The Ohio State University Research Foundation | Her-2 peptides |
| US8945573B2 (en) * | 2005-09-08 | 2015-02-03 | The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. | Targeted identification of immunogenic peptides |
| WO2008097229A1 (en) * | 2007-02-09 | 2008-08-14 | The Government Of The Usa As Represented By The Secretary Of The Dept. Of Health And Human Services | Method for spectroscopic quantitation of her-2 in biological samples |
| US20110044882A1 (en) * | 2008-04-22 | 2011-02-24 | David Buckley | Method of making high purity lithium hydroxide and hydrochloric acid |
| US20100234283A1 (en) | 2009-02-04 | 2010-09-16 | The Ohio State University Research Foundation | Immunogenic epitopes, peptidomimetics, and anti-peptide antibodies, and methods of their use |
| US9125848B2 (en) | 2010-06-10 | 2015-09-08 | The Cleveland Clinic Foundation | Alpha lactalbumin immunization methods |
| RU2607033C2 (ru) * | 2010-09-28 | 2017-01-10 | Ноно Инк. | Пептиды nd2 и способы лечения неврологического заболевания |
| CA2870537A1 (en) | 2012-04-16 | 2013-10-24 | The Cleveland Clinic Foundation | Multivalent breast cancer vaccine |
| US10221230B2 (en) | 2013-02-25 | 2019-03-05 | Ohio State Innovation Foundation | HER-1, HER-3 and IGF-1R compositions and uses thereof |
| CN105017425B (zh) * | 2014-04-30 | 2018-02-16 | 京天成生物技术(北京)有限公司 | 抗her2中和活性单克隆抗体及其应用 |
| US20180327453A1 (en) * | 2015-11-06 | 2018-11-15 | Evorx Technologies, Inc. | Her-2-specific cyclized supr peptides |
| WO2018145020A1 (en) | 2017-02-03 | 2018-08-09 | The Medical College Of Wisconsin, Inc. | Kras peptide vaccine compositions and method of use |
| ES2963635T3 (es) * | 2017-03-28 | 2024-04-01 | Ohio State Innovation Foundation | Vacunas de péptido PD1 humano y usos de las mismas |
| US20200179500A1 (en) | 2018-12-05 | 2020-06-11 | Wayne State University | Methods and immunogenic compositions relating to her2 with selective sequence modifications |
| CN113993902B (zh) * | 2019-03-22 | 2025-03-14 | 瑟缇斯治疗私人有限公司 | 抗her2结合分子 |
| BR112022005044A2 (pt) * | 2019-09-17 | 2022-07-05 | Ohio State Innovation Foundation | Peptídeo quimérico, peptídeo sintético, composição farmacêutica, anticorpo, método de tratamento |
| EP4486389A1 (en) | 2022-02-28 | 2025-01-08 | Tridem Bioscience GmbH & Co KG | A conjugate comprising at least a beta-glucan |
| CN119019569B (zh) * | 2024-08-19 | 2025-10-24 | 中国人民解放军陆军军医大学 | 一种可定向增强胸腺新生t细胞杀伤乳腺癌的多肽及其应用 |
Family Cites Families (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3040121B2 (ja) | 1988-01-12 | 2000-05-08 | ジェネンテク，インコーポレイテッド | 増殖因子レセプターの機能を阻害することにより腫瘍細胞を処置する方法 |
| DE69031120T2 (de) | 1989-05-19 | 1998-01-15 | Genentech, Inc., South San Francisco, Calif. | Her2 extrazellulare domäne |
| WO1991011719A1 (en) | 1990-01-26 | 1991-08-08 | Washington Research Foundation | Immune reactivity to expressed activated oncogenes for diagnosis and treatment of malignancy |
| IL101943A0 (en) | 1991-05-24 | 1992-12-30 | Genentech Inc | Structure,production and use of heregulin |
| CA2138997C (en) | 1992-06-25 | 2003-06-03 | Jean-Paul Prieels | Vaccine composition containing adjuvants |
| DE69333588T2 (de) | 1992-09-28 | 2005-08-04 | Wyeth Holdings Corp. | Verfahren zur verstärkung zellularer immunantworten |
| AU679902B2 (en) | 1992-09-30 | 1997-07-17 | Ohio State University Research Foundation, The | Vaccines and antigenic conjugates |
| US5801005A (en) | 1993-03-17 | 1998-09-01 | University Of Washington | Immune reactivity to HER-2/neu protein for diagnosis of malignancies in which the HER-2/neu oncogene is associated |
| US5869445A (en) | 1993-03-17 | 1999-02-09 | University Of Washington | Methods for eliciting or enhancing reactivity to HER-2/neu protein |
| GB9326253D0 (en) | 1993-12-23 | 1994-02-23 | Smithkline Beecham Biolog | Vaccines |
| EP1167379A3 (en) | 1994-07-15 | 2004-09-08 | University Of Iowa Research Foundation | Immunomodulatory oligonucleotides |
| UA56132C2 (uk) | 1995-04-25 | 2003-05-15 | Смітклайн Бічем Байолоджікалс С.А. | Композиція вакцини (варіанти), спосіб стабілізації qs21 відносно гідролізу (варіанти), спосіб приготування композиції вакцини |
| US6410022B1 (en) | 1995-05-01 | 2002-06-25 | Avant Immunotherapeutics, Inc. | Modulation of cholesteryl ester transfer protein (CETP) activity |
| WO1997038011A1 (en) | 1996-04-03 | 1997-10-16 | Pepresearch A/S | Non-dendritic backbone peptide carrier |
| KR20060079258A (ko) | 1996-10-18 | 2006-07-05 | 제넨테크, 인크. | 항-ＥｒｂＢ２ 항체 |
| CN1181422A (zh) | 1996-10-31 | 1998-05-13 | 上海市肿瘤研究所 | 与生长因子受体结合的多肽所构建的基因转移载体 |
| JP2001513369A (ja) | 1997-08-11 | 2001-09-04 | アラーガン・セイルズ・インコーポレイテッド | 改善された生物適合性を有する無菌の生物侵食性の移植デバイスおよび方法 |
| ZA9811162B (en) | 1997-12-12 | 2000-06-07 | Genentech Inc | Treatment with anti-ERBB2 antibodies. |
| EP0953823A2 (en) | 1998-05-01 | 1999-11-03 | Aisin Cosmos R & D Co. Ltd. | Micro yaw rate sensors |
| WO2000034337A1 (en) | 1998-12-10 | 2000-06-15 | Tsukuba Research Laboratory, Toagosei Co., Ltd. | Humanized monoclonal antibodies against vascular endothelial cell growth factor |
| DE60040981D1 (de) | 1999-05-14 | 2009-01-15 | Genentech Inc | BEHANDLUNG MIT ANTI-ErbB2 ANTIKÖRPERN |
| EP1246597B1 (en) | 1999-08-03 | 2015-01-14 | The Ohio State University | Polypeptides and polynucleotides for enhancing immune reactivity to her-2 protein |
| US6432409B1 (en) | 1999-09-14 | 2002-08-13 | Antigen Express, Inc. | Hybrid peptides modulate the immune response |
| US20030235594A1 (en) * | 1999-09-14 | 2003-12-25 | Antigen Express, Inc. | Ii-Key/antigenic epitope hybrid peptide vaccines |
| EP1366153A2 (en) * | 2000-08-14 | 2003-12-03 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of her-2/neu-associated malignancies |
| GB0213878D0 (en) | 2002-06-17 | 2002-07-31 | Protherics Plc | Use |
| CA2499123A1 (en) * | 2002-09-17 | 2004-04-15 | Antigen Express, Inc. | Ii-key/antigenic epitope hybrid peptide vaccines |
| EP2287315A1 (en) * | 2003-03-04 | 2011-02-23 | Intercell AG | Streptococcus pyogenes antigens |
| DE602004026445D1 (de) * | 2003-06-25 | 2010-05-20 | Ottawa Health Research Inst | Verwendung von cardiotrophin zur modulation der stammzellenproliferation |
| US7473682B2 (en) * | 2003-10-29 | 2009-01-06 | Ramot At Tel Aviv University Ltd. | Angiogenic peptides and uses thereof |
| CA2555274A1 (en) | 2004-02-05 | 2005-08-25 | The Ohio State University Research Foundation | Chimeric vegf peptides |
| SE0402565L (sv) | 2004-10-19 | 2005-12-20 | Mia Kumm | Anordning och system för ventilation av tunnel vid brand |
| CN101087878A (zh) | 2004-12-20 | 2007-12-12 | 味之素株式会社 | 具有肽合成活性的突变型蛋白质 |
| AU2006261342B2 (en) | 2005-06-15 | 2012-02-02 | The Ohio State University Research Foundation | Her-2 peptides |
| US20100234283A1 (en) | 2009-02-04 | 2010-09-16 | The Ohio State University Research Foundation | Immunogenic epitopes, peptidomimetics, and anti-peptide antibodies, and methods of their use |
| JP5510272B2 (ja) | 2010-06-21 | 2014-06-04 | 株式会社リコー | 画像形成装置 |
-
2006
- 2006-06-15 AU AU2006261342A patent/AU2006261342B2/en not_active Ceased
- 2006-06-15 JP JP2008517193A patent/JP5222134B2/ja not_active Expired - Fee Related
- 2006-06-15 US US11/424,526 patent/US7691396B2/en active Active
- 2006-06-15 ES ES06785065.1T patent/ES2531483T3/es active Active
- 2006-06-15 CA CA2612394A patent/CA2612394C/en active Active
- 2006-06-15 WO PCT/US2006/023672 patent/WO2006138675A2/en not_active Ceased
- 2006-06-15 EP EP06785065.1A patent/EP1912680B1/en not_active Not-in-force
-
2010
- 2010-02-01 US US12/697,578 patent/US8470333B2/en active Active
-
2012
- 2012-04-17 JP JP2012093680A patent/JP5542865B2/ja not_active Expired - Fee Related
-
2013
- 2013-05-30 US US13/905,996 patent/US9452204B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2009500298A5 (https=) | ||
| JP2014224121A5 (https=) | ||
| HRP20211318T1 (hr) | Mutirani polipeptidi interleukina-2 | |
| ES2332590T3 (es) | Dimero peptidico. | |
| HRP20201770T1 (hr) | Nova imunoterapija protiv raznih vrsta karcinoma, uključujući gastrointestinalni karcinom i gastrični karcinom | |
| RU2016101711A (ru) | Высокостабильный т-клеточный рецептор и способ его получения и применения | |
| JP2016196472A5 (https=) | ||
| JP2003530074A5 (https=) | ||
| JP2016199557A5 (https=) | ||
| JP2018171063A5 (https=) | ||
| JP2012501959A5 (https=) | ||
| JP2006526414A5 (https=) | ||
| JP2017537926A5 (https=) | ||
| JP2010502207A5 (https=) | ||
| JP2006504653A5 (https=) | ||
| JP2016512213A5 (https=) | ||
| JP2016516061A5 (https=) | ||
| JP2015537044A5 (https=) | ||
| HRP20190799T1 (hr) | Imunocitokini na bazi il-15 i sushi domene il-15r alfa | |
| JP2016153410A5 (https=) | ||
| JP2013529078A5 (https=) | ||
| JP2013121977A5 (https=) | ||
| CN112584858A (zh) | 抗原性ospa多肽 | |
| JP2013517783A5 (https=) | ||
| JP2022553826A5 (https=) |